Wei, Feifei http://orcid.org/0000-0002-5770-3255
Sasada, Tetsuro http://orcid.org/0000-0002-2313-8833
Article History
Received: 14 November 2023
Revised: 24 November 2023
Accepted: 27 November 2023
First Online: 14 December 2023
Competing interests
: TS received honoraria from Chugai and Bristol Myers Squibb, and research funds from Taiho and BrightPath Biotherapeutics.
: Participants in the original study provided informed consent, and the study design was approved by Institutional Review Boards of Kurume University Hospital (approval numbers: 15210 and 19240) and Kanagawa Cancer Center (approval number: 2019-131).